Management of Graves' Disease Symptoms

Diagnostic Confirmation

The American College of Physicians recommends confirming diagnosis with TSH, Free T4, and considering TSH receptor antibody testing if clinical features suggest Graves' disease 1
Physical examination findings of ophthalmopathy or thyroid bruit are diagnostic of Graves' disease and should prompt early endocrine referral, as suggested by the Journal of Clinical Oncology 2
Imaging (CT or MRI) can confirm diagnosis and evaluate extraocular muscle enlargement and orbital fat volume in patients with thyroid eye disease, according to Ophthalmology 3

The American Association of Clinical Endocrinologists recommends methimazole as the preferred first-line agent for most patients with Graves' disease 1
Titrate dose based on thyroid function tests, with goal to maintain FT4 in high-normal range using lowest possible dose, as recommended by the American College of Physicians 1
Monitor thyroid function every 4-6 weeks during initial treatment phase, then every 2-3 months once stable, according to the American Association of Clinical Endocrinologists 1
For persistent hyperthyroidism (>6 weeks), refer to endocrinology for additional workup and possible medical thyroid suppression, as suggested by the Journal of Clinical Oncology 2

Beta-blockers (e.g., atenolol or propranolol) provide symptomatic relief of tachycardia, tremor, and anxiety, according to the Journal of Clinical Oncology 2
Ocular lubricants are almost always needed to combat exposure related to eyelid retraction and proptosis in patients with thyroid eye disease, as recommended by Ophthalmology 3
Selenium supplementation may reduce inflammatory symptoms in patients with milder thyroid eye disease, according to Ophthalmology 3
Teprotumumab (IGF-IR inhibitor) reduces proptosis and clinical activity score in patients with active thyroid eye disease, as suggested by Ophthalmology 3

For pregnant women, switch from methimazole to propylthiouracil during planning pregnancy and first trimester, as recommended by the American College of Obstetricians and Gynecologists 1
For elderly patients (>70 years) or those with comorbidities, consider starting with lower doses of thyroid replacement if hypothyroidism develops, according to the Journal of Clinical Oncology 2
For patients with severe symptoms affecting activities of daily living, consider holding immune checkpoint inhibitors (if applicable) until symptoms resolve, as suggested by the Journal for ImmunoTherapy of Cancer 4

For patients who don't respond to antithyroid drugs after 12-18 months, consider radioactive iodine therapy or thyroidectomy, as recommended by the American Association of Clinical Endocrinologists 1
Radioactive iodine is contraindicated in pregnancy, breastfeeding, and patients with active/severe orbitopathy, according to the American College of Radiology 1
Thyroidectomy should be performed by an experienced high-volume thyroid surgeon, as suggested by the American Thyroid Association 1

For moderate-to-severe thyroid eye disease, consider orbital decompression, high-dose steroids, or radiation treatment, according to Ophthalmology 3
If orbital decompression is indicated, strabismus repair should be delayed until after the decompression, as recommended by Ophthalmology 3
Fresnel or ground-in prism can provide temporary relief from diplopia while awaiting definitive treatment, according to Ophthalmology 3

Hospitalize patients with severe symptoms for intensive management, as recommended by the American College of Emergency Physicians 1
Use beta-blockers, high-dose antithyroid drugs, and consider additional therapies such as steroids and saturated solution of potassium iodide (SSKI), according to the American Association of Clinical Endocrinologists 1
Endocrine consultation is recommended for all patients with severe symptoms, as suggested by the Journal for ImmunoTherapy of Cancer 4

Failing to recognize transition from hyperthyroidism to hypothyroidism, which is common with thyroiditis, as warned by the American College of Physicians 1
Not monitoring thyroid function closely enough (every 2-3 weeks after diagnosis) to catch transition to hypothyroidism, according to the Journal of Clinical Oncology 2
Using radioactive iodine in pregnant or breastfeeding women, as contraindicated by the American College of Radiology 1
Initiating thyroid hormone before steroids in patients with both adrenal insufficiency and hypothyroidism, as cautioned by the Journal for ImmunoTherapy of Cancer 4

High‑dose corticosteroids (≈1 mg/kg/day) are not routinely required for managing thyroid dysfunction caused by immune checkpoint inhibitors; treatment can be limited to observation and symptomatic care. 5
Beta‑blockers are the preferred agents for controlling symptoms (e.g., tachycardia, tremor) during the hyperthyroid phase of checkpoint‑inhibitor‑induced thyroiditis. 5

Continuous high‑dose corticosteroid therapy should be avoided for long‑term control of Graves’ hyperthyroidism because it carries serious and potentially irreversible side‑effects (e.g., metabolic, musculoskeletal, infectious complications). 6